Showing 5,281 - 5,300 results of 18,405 for search 'significantly ((((((we decrease) OR (nn decrease))) OR (a decrease))) OR (observed decrease))', query time: 0.82s Refine Results
  1. 5281

    Cortical and subcortical regions feature distinct early and late responses during audition. by Sarah H. McGill (22505225)

    Published 2025
    “…The mean no-stimulus trial spectrograms were subtracted from the mean maximum-intensity trial spectrograms, and a cluster-based permutation testing was employed to identify significant differences between the conditions (p < 0.05, 5000 iterations). …”
  2. 5282

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  3. 5283

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  4. 5284

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  5. 5285

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  6. 5286

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  7. 5287

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  8. 5288

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  9. 5289

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  10. 5290

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  11. 5291

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  12. 5292

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  13. 5293

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  14. 5294

    Regional work heterogeneity in LBBB differs between responders and non-responders, but LV stroke work, myocardial work, and efficiency do not. by Amanda Craine (19832365)

    Published 2024
    “…(D) Regional work heterogeneity (COVW) was significantly (p<0.05) higher at baseline in responders than non-responders and only decreased significantly after CRT (p = 0.05) in the responder group.…”
  15. 5295

    Passive listening and go/No-go tasks feature comparable electrophysiological responses. by Sarah H. McGill (22505225)

    Published 2025
    “…The mean no-stimulus trial spectrograms were subtracted from the mean maximum-intensity trial spectrograms, and a cluster-based permutation testing was employed to identify significant differences between the conditions (p < 0.05, 5000 iterations). …”
  16. 5296
  17. 5297

    Comparison of hemodynamic data. by Seung-Jae Joo (3620240)

    Published 2024
    “…After handgrip exercise, an increase in E<sub>LV</sub>I (<i>P</i> = 0.021) and a decrease in VAC (<i>P</i> = 0.035) were observed specifically in men, with no corresponding changes noted in women. …”
  18. 5298

    Comparison of echocardiographic data. by Seung-Jae Joo (3620240)

    Published 2024
    “…After handgrip exercise, an increase in E<sub>LV</sub>I (<i>P</i> = 0.021) and a decrease in VAC (<i>P</i> = 0.035) were observed specifically in men, with no corresponding changes noted in women. …”
  19. 5299

    Minimal raw clinical data with anonymization. by Seung-Jae Joo (3620240)

    Published 2024
    “…After handgrip exercise, an increase in E<sub>LV</sub>I (<i>P</i> = 0.021) and a decrease in VAC (<i>P</i> = 0.035) were observed specifically in men, with no corresponding changes noted in women. …”
  20. 5300

    Baseline characteristics of patients. by Seung-Jae Joo (3620240)

    Published 2024
    “…After handgrip exercise, an increase in E<sub>LV</sub>I (<i>P</i> = 0.021) and a decrease in VAC (<i>P</i> = 0.035) were observed specifically in men, with no corresponding changes noted in women. …”